Condition
Hypergastrinaemia
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (3)
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01339169Phase 2Completed
YF476 and Type I Gastric Carcinoids
NCT01699113Phase 1CompletedPrimary
Effects of YF476 and Rabeprazole on Gastric Function
NCT01601418Phase 1CompletedPrimary
Effect of Single Doses of YF476 on Stomach Acidity
NCT01601405Phase 1CompletedPrimary
Effect of Repeated Doses of YF476 on Stomach Acidity
Showing all 4 trials